In-Silico Approach of Mole Crab (Emerita sp.) Peptides Produced by Alcalase Hydrolysis
Squalen Bulletin of Marine and Fisheries Postharvest and Biotechnology · 2025
DOI: 10.15578/squalen.1018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Squalen Bulletin of Marine and Fisheries Postharvest and Biotechnology, 2025. Verfasst von Romadhon Romadhon und 5 weiteren Autor:innen.
Abstract (Originalsprache)
One type of mole crab in Indonesia is Emerita sp., which has a fatty acid content of 3.57% and crude protein content of 32.42% (100 mg). The use of mole crabs is currently limited to food sources; therefore, it is necessary to conduct research to optimize the use of mole crabs, which are a source of protein hydrolysate. The samples were used under fresh conditions and stored at −20°C before processing. This study aimed to produce protein hydrolysates from moles of crabs. This hydrolysate is produced by enzymatic hydrolysis of marine back-down raw materials using alcalase. In silico analyses have identified the potential of marine-receding protein hydrolysates. The results of in silico analysis using BIOPEP and Peptide Ranker revealed that these peptides exhibited multiple bioactivities, including ACE inhibition, DPP-IV inhibition, and antioxidative and anti-inflammatory effects. The dipeptide PW (Pro-Trp) achieved the highest Peptide Ranker score of 0.993, with a predicted dual function as an antioxidant and DPP-IV inhibitor. Molecular docking confirmed strong binding affinities to target receptors, with the AF peptide displaying the best interaction against ACE (−129.70 kcal/mol) and GH peptide against DPP-IV (−113.68 kcal/mol). These results suggest that mole crab hydrolysate contains promising peptides with potential applications as nutraceuticals, particularly in the management of hypertension and type 2 diabetes mellitus. The highest potency based on the in-silico peptide hydrolysate has a strong antihypertensive effect. Further in vivo research is needed to explain the potential of sea retreat peptides as bioactive antihypertensive agents in peptide form.
Zitieren
APA
Romadhon, R., Sabdono, A., Subagyo, S., Triyanto, A., Riyadi, P. H., & Amalia, U. (2025). In-Silico Approach of Mole Crab (Emerita sp.) Peptides Produced by Alcalase Hydrolysis. Squalen Bulletin of Marine and Fisheries Postharvest and Biotechnology. https://doi.org/10.15578/squalen.1018
Vancouver
Romadhon R, Sabdono A, Subagyo S, Triyanto A, Riyadi PH, Amalia U. In-Silico Approach of Mole Crab (Emerita sp.) Peptides Produced by Alcalase Hydrolysis. Squalen Bulletin of Marine and Fisheries Postharvest and Biotechnology. 2025. doi:10.15578/squalen.1018
BibTeX
@article{Romadhon2025,
author = {Romadhon, Romadhon and Sabdono, Agus and Subagyo, Subagyo and Triyanto, Agus and Riyadi, Putut Har and Amalia, Ulfah},
title = {In-Silico Approach of Mole Crab (Emerita sp.) Peptides Produced by Alcalase Hydrolysis},
journal = {Squalen Bulletin of Marine and Fisheries Postharvest and Biotechnology},
year = {2025},
doi = {10.15578/squalen.1018}
}
EUVIMED